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PRECLINICAL RESEARCH
reatment of Ischemic Limbs Based on
ocal Recruitment of Vascular Endothelial
rowth Factor-Producing Inflammatory
ells With Ultrasonic Microbubble Destruction
unji Yoshida, MD, Koji Ohmori, MD, PHD, Hiroto Takeuchi, MD, PHD, Kaori Shinomiya, MD, PHD,
sunetatsu Namba, MD, PHD, Isao Kondo, MD, PHD, Hideyasu Kiyomoto, MD, PHD,
asakazu Kohno, MD, PHD
agawa, Japan
OBJECTIVES We sought to clarify the mechanism for neovascularization by ultrasonic microbubble
destruction (US/MB) and its ability to improve the function of ischemic limbs.
BACKGROUND In tissue, US/MB can cause capillary rupture, leading to angiogenesis and arteriogenesis.
METHODS Seven days after removal of the femoral artery (day 0) in mice, microbubble/ultrasound treatment
was performed by intermittent insonation (1.6 MHz, mechanical index 1.1) to the ischemic limbs
after intravenous infusion of phospholipid-stabilized microbubbles BR14 (US/MB group). Effects
were compared with those in untreated mice with ischemic limbs (control group).
RESULTS Immunostaining of the treated muscles revealed a greater leukocyte (CD45-positive cell)
count in the US/MB group on days 3 and 7. These cells included F4/80-positive cells
(macrophages) and CD3-positive cells (T-lymphocytes), both of which were immunoreactive
to vascular endothelial growth factor (VEGF) antibody. Muscular VEGF content by Western
blotting was elevated in the US/MB group on day 3, which declined but remained greater
until day 21. The US/MB group showed a greater capillary density by alkaline phosphatase
stain on day 7 without further increase at day 21. Surface vascularity of the muscles and blood
flow were greater in the US/MB group on day 7, which further increased by day 21.
Moreover, the US/MB group showed a two-fold longer treadmill time compared with the
untreated control group on day 21. None of these favorable effects were observed in mice
treated with ultrasound only or microbubbles only.
CONCLUSIONS Ultrasonic destruction of microbubbles delivered to the ischemic limbs can recruit inflam-
matory cells producing VEGF, which is followed by neovascularization and functional
improvement, and thus has a therapeutic potential. (J Am Coll Cardiol 2005;46:899–905)


















uherapeutic neovascularization in ischemic tissues has been
timulated by the targeted delivery of vascular growth factor
VGF) genes (1) and proteins (2). However, a considerable
ngiogenic effect of the “control” adenoviral agent, which
as directly injected into the skeletal muscle, was reported
3). Acupuncture to the myocardium was also reported to
nduce angiogenesis (4). Transmyocardial laser revascular-
zation therapy elicits neovascularization, which is hypoth-
sized to follow an inflammatory response (5). Therefore,
nduction of inflammation by local injury attributable to
irect injection itself or to proinflammatory stimuli may
ause neovascularization. Moreover, although bone
arrow-derived mononuclear cells have been transplanted
nto the ischemic tissue for neovascularization as the source
f endothelial progenitor cells, a significant role for inflam-
atory cells that also differentiate from this cell fraction and
roduce VGFs has also been noted (6). Thus, inflammatory
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ccepted May 10, 2005.ells producing VGFs may play key roles in therapeutic
ngiogenesis.
Because microbubble destruction in tissue microcircula-
ion by ultrasound can cause capillary rupture, we (7,8) and
ther investigators (9,10) have used this phenomenon as a
icroinjection in enhancing protein or gene delivery to
arget organs. Recently, microbubble destruction itself was
ound to stimulate angiogenesis and arteriogenesis in arte-
ially occluded (11) as well as normal (12) skeletal muscles in
ats, resulting in restoration of blood flow during adenosine
nfusion. Although it was hypothesized that recruitment of
nflammatory cells might follow capillary rupture to play a
ole in this phenomenon, no direct evidence has been
rovided. Moreover, although it was shown that this phe-
omenon restored blood flow distal to the occluded artery
uring pharmacologic vasodilation, its therapeutic potential
or limb ischemia limiting exercise capacity remains to be
ested.
The purposes of this study were to examine whether
ltrasonic microbubble destruction (US/MB) can enhance
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egarding the role of local inflammatory cell infiltration, and
o examine whether the neovascularization thus induced
rovides functional improvement of the diseased limbs.
ETHODS
ouse model of limb ischemia. The study protocols were
pproved by the Institutional Animal Care and Use Com-
ittee of Kagawa University School of Medicine. In wild-
ype mice (C57BL/6, Charles River Japan, Yokohama,
apan), the entire right femoral artery and vein were
urgically excised under anesthesia with sodium pentobar-
ital (50 mg/kg intraperitoneally) to produce hind limb
schemia (13).
reatments with ultrasound and/or microbubbles. Seven
ays after surgery (day 0), the mice were anesthetized by an
ntraperitoneal injection of 50 mg/kg pentobarbital and the
ight jugular vein was cannulated. A saline solution of
icrobubbles (BR14, Bracco SA, Geneva, Switzerland) at a
oncentration of 2 to 5  108 microbubbles/ml (14) was
lowly injected at 2.4 ml/h for 3 min so that approximately
.4 to 6.0 108 microbubbles were administered. The hind
imb to be treated was placed in a custom-designed acoustic
oupler for ultrasound exposure. The insonation was per-
ormed with an S3 transducer of a SONOS 5500 (Philips
edical Systems, Andover, Massachusetts) in five consec-
tive transverse planes from proximal to distal levels of the
ind limb, leaving no uninsonified segments between the
lanes. We used the harmonic power Doppler mode at
.6-MHz transmission frequency with a mechanical index
f 1.1 to obtain the short-axis image of the limb in the
enter of the imaging plane, where the acoustic focus was
laced (Fig. 1). We suspended the insonation during the
njection of BR14 until it was started at the most proximal
evel with a burst of 20 frames in the multi-frame trigger
ode at every 99th cardiac cycle. Then the transducer was
erially moved to the next segment for the same insonation
rocedure until the most distal segment (the fifth segment)
as insonated. The series of proximal to distal scans was
epeated five times for sufficient destruction of re-circulating
icrobubbles. During the treatment, microbubble delivery
o the ischemic limbs was confirmed by the apparent
pacification of the first frame of each burst. In the second
roup, insonation was performed in the same manner
ithout pre-infusion of microbubbles (US group). The
hird group received microbubble infusion that was not
Abbreviations and Acronyms
mAb  monoclonal antibody
T-PBS  phosphate-buffered saline with 0.2% Tween
US/MB ultrasonic destruction of microbubbles
VEGF  vascular endothelial growth factor
VGF(s)  vascular growth factor(s)ollowed by insonation (MB group). In the control group, mo insonation or infusion of microbubbles was performed.
hen, subgroups of mice in each group were euthanized 3,
, or 21 days after treatments to assess capillary density,
nflammatory cell infiltration, vascular endothelial growth
actor (VEGF) expression, collateral vessel formation (arte-
iogenesis), or blood flow. Ten to 18 mice were euthanized
n day 0 (before treatment) to obtain baseline data for each
ssessment. Six to 12 mice in each group were subjected to
erial treadmill tests performed immediately before, 7 days
fter, and 21 days after treatment.
istologic assessments. Skeletal muscles harvested from
he treated limbs after euthanasia were either fixed in neu-
ral 10% formalin and embedded in paraffin or frozen in
issue-Tek OCT compound (Sakura Finetek U.S.A., Inc.,
orrance, California) and stored at 80°C until sectioning
or histologic assessments.
apillary density. Capillary density within the ischemic
high adductor muscles was analyzed to evaluate vascularity
t the level of microcirculation. Three pieces of the ischemic
uscles harvested from each animal were embedded in OCT
ompound. Tissue sections (5 m in thickness) were cut from
ach specimen on a cryostat so that the muscle fibers were
riented in a transverse fashion, and then were placed on
lass slides. Sections were stained for alkaline phosphatase
o detect capillary endothelial cells (8), and were then
ounterstained with eosin. Three random microscopic fields
t 400 magnification from each slice were examined to
valuate capillary density as the number of capillaries per
igh-power field (15).
ocal inflammatory response. One tissue slice adjacent to
he one for alkaline phosphatase stain was subjected to
mmunohistochemical staining using an anti-mouse mono-
lonal antibody (mAb) to a common leukocyte antigen
D45 (PharMingen, San Diego, California) (15). Briefly,
ections were fixed with acetone and were incubated with
he primary antibody and thereafter with horseradish
eroxidase-conjugated antibody. Sections were colorized
ith diaminobenzidine and were counterstained with he-
igure 1. Representative images during treatment by ultrasound and
icrobubbles. Dense opacification of the short-axis image of the mouse
ind limb was obtained on the first frame of the multi-frame trigger mode
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er high-power field.
EGF expression in inflammatory mononuclear cells. We
xamined VEGF expression in mononuclear cells in treated
imbs using a double immunofluorescence staining tech-
ique (15). Cryostat sections, 5 m in thickness, from
schemic tissues were mounted on silicone-coated slides.
hey were then incubated overnight at 4°C with goat
nti-mouse VEGF mAb (Santa Cruz Biotechnology, Santa
ruz, California) and either of a marker of macrophages, rat
nti-mouse F4/80 mAb (Dainippon Pharmaceutical,
saka, Japan) or that of T-lymphocytes, rat anti-mouse
D3 mAb (CALTAG Laboratories, Burlingame, Califor-
ia). The slides were then incubated for 30 min at 37°C
ith a fluorescein isothiocyanate-conjugated anti-goat im-
unoglobulin G secondary antibody (Vector Laboratories,
urlingame, California) to detect VEGF. Then they were
urther incubated for 30 min at 37°C with Texas red
sothiocyanate-conjugated anti-rat immunoglobulin G
P.A.R.I.S., Compiegne, France) to detect macrophages or
-lymphocytes. The slides were examined and photo-
raphed using a laser confocal microscope LSM-GB200
Olympus, Tokyo, Japan) using optimal combinations of
pecific excitation and emission filters for co-localization
nalysis by dual fluorescence staining.
estern blot analysis. Protein extracts were obtained from
omogenized ischemic skeletal muscles. Twenty micro-
rams of protein per sample was separated on a 12.5%
olyacrylamide gel and electroblotted onto polyvinylidene
uoride membranes (Amersham Biosciences, Piscataway,
ew Jersey). The membrane was blocked with 10% nonfat
ry milk in phosphate-buffered saline with 0.2% Tween
T-PBS) and then probed with a goat polyclonal anti-
ouse VEGF antibody (Santa Cruz Biotechnology) for 3 h
t room temperature. After incubation with the primary
ntibody, the membrane was washed in T-PBS and then
ncubated for 1 h with anti-goat immunoglobulin G con-
ugated with horseradish peroxidase. The membrane was
hen washed in T-PBS, and antigen-antibody complexes
ere visualized using an enhanced chemiluminescence kit
PerkinElmer, Boston, Massachusetts), followed by expo-
ure to chemiluminescence films (Hyperfilm, Amersham
iosciences) (15).
nalysis of surface vascularity of skeletal muscles. The
keletal muscles were exposed through the skin incision
rom the thigh to the ankle. Then, the surface vasculature
as observed through the fascia by an intravital microscope
stereomicroscope Leica MZ6, Leica Microsystems, Tokyo,
apan) at32 magnification and was digitally recorded. We
uantitated the vascularity by the grid method (16). In brief,
isible vessels were manually traced on the printout of the
agnified digital images, allowing minimal diameter of
raceable vessels of approximately 0.01 mm. Subsequently, a
irtual grid (equivalent to 0.3  0.3 mm in tissue) was
uperimposed on the printout with the trace lines of vessels
t an angle of approximately 45° to the long axis of the limb. Vhen, we counted the intersections of the trace lines and
rid lines for the entire length of the limb to quantitate the
ascularity as the number of intersections per square centi-
eter of surface area of the limb.
icrosphere analysis. Blood flow to the ischemic muscles
as assessed with the microsphere technique (11,17). In
rief, red fluorescent microspheres (Fluo Spheres, 15 m,
olecular Probes, Inc., Eugene, Oregon) were injected into
he left ventricle (150,000 particles) for 1 min before
uthanasia. The adductor muscles in the treated ischemic
nd control non-ischemic limbs were then dissected and
rozen. Microspheres were visually counted in the 70-m
ross-sectional slices with a fluorescence microscope (BX-
1, Olympus) at 100 magnification to assess the blood
ow in the treated limbs as the percent of control non-
schemic limbs.
readmill walk test. To quantitate the total leg function,
e serially performed treadmill exercise testing using the
ota Rod Treadmill 7600 for mice (Ugo Basile, Varese,
taly). Mice were placed on the horizontal rotating rod
3-cm diameter, 24 rpm). Then the duration on the rod was
easured, which was repeated after a 30-min interval for a
omplete recovery, and the average of the two measure-
ents was used.
tatistics. All values are presented as the mean  standard
rror of the mean. Analysis of variance followed by the
ost-hoc Student-Newman-Keuls test was used in all pair-
ise comparisons (six comparisons) among the four groups.
value of p  0.05 was considered to be statistically
ignificant. The statistical package SigmaStat, version 2.03
Jandel Scientific, San Rafael, California), was used for
tatistical analyses.
ESULTS
wenty of 249 mice died before treatment, during either
urgery or cannulation. Forty mice were used for baseline
ssessments, and the remaining 189 mice were subjected to
ne of the four treatments. No mice died during treatment
r follow-up, until they were euthanized for the scheduled
valuations.
nflammatory cell infiltration. Figure 2 compares serial
hanges in leukocyte infiltration. The CD45-positive cell
ount gradually decreased in the control, US, and MB
roups; however, the US/MB group showed a three-fold
igher cell count than the other three groups three days after
reatment (Fig. 2A), which persisted at day 7 (Fig. 2B).
roduction of VEGF by infiltrating cells. Figure 3 shows
he results of double immunofluorescence staining of mac-
ophages and VEGF (Fig. 3, top) and that of
-lymphocytes and VEGF (Fig. 3, bottom) obtained from
he US/MB group on day 3. Distribution of the infiltrated
ells agreed well with that of VEGF for both cell types,
uggesting that the infiltrated leukocytes included macro-
























































902 Yoshida et al. JACC Vol. 46, No. 5, 2005
Neovascularization by Ultrasound-Microbubble September 6, 2005:899–905issue VEGF concentration. Representative Western
lot photographs comparing the control and US/MB group
re shown in Figure 4. The VEGF concentration in the
reated skeletal muscle decreased in the untreated control
igure 2. (A) Representative photomicrographs of CD45 immunostaining
f treated muscles on day 3. Bars indicate 50 m. (B) The count of
eukocytes defined as CD45-positive cells. The CD45-positive cell count
as significantly higher in the US/MB group than in the other groups after
reatment. (n  10 for baseline, three mice were used for each subsequent
olumn.) *p  0.001 vs. the other groups by analysis of variance with
tudent-Newman-Keuls post-hoc test. US/MB  treated with both
ltrasound and microbubbles; US  treated with microbubbles only; MB
treated with microbubbles only.
igure 3. Expression of vascular endothelial growth factor (VEGF) by
eukocytes. Double immunofluorescence stain revealed that distribution of
acrophages (F4/80-positive) (top) and that of T-lymphocytes (CD3-t
ositive) (bottom) are both super-imposable onto the corresponding
EGF stain. Bars indicate 50 m.roup but was increased at day 3 in the US/MB group,
esulting in higher expression throughout the observation
ompared with control (panel A). Although VEGF concen-
ration was similarly reduced in the US group and the MB
roup, the US/MB group showed a marked elevation of
EGF concentration three days after treatment, which re-
ained higher than the other groups until day 21 (panel B).
apillary density. Figure 5 shows capillary angiogenesis. A
arked increase in capillaries was noted at day 7 only in the
S/MB group (panel A). Capillary density was higher, by
bout 30%, in the US/MB group than in the other groups
t day 7. Although no further increase at day 21 was ob-
erved, the capillary density remained higher in the US/MB
roup than in the other groups (panel B).
urface vascularity. Panel A in Figure 6 shows photo-
raphs of vasculature on the surface of the skeletal muscles
rom an untreated mouse (left) and that in the US/MB
roup (right) obtained 21 days after treatment. A marked
ncrease in vascularity in the US/MB mice compared with
ontrols was apparent. The vascularity was 1.5-fold higher
n the US/MB group than in the other groups at day 7,
hich was further increased at 21 days after treatment
panel B).
lood flow. Figure 7 compares alterations in blood flow in
he treated ischemic limbs. Although only a small increase
n blood flow was observed in the control, US, and MB
roups, the US/MB group showed significantly greater
mprovement of blood flow, which was 71% of non-
schemic on day 7 and 89% on day 21.
readmill time. Figure 8 compares treadmill time, which
igure 4. (A) Representative Western blot photographs showing gradual
ecrease of vascular endothelial growth factor (VEGF) in the control group
nd re-increase of VEGF expression by US/MB treatment. (B) Such an
ffect was seen only in the US/MB group. (n  18 for baseline, n  3 to
for each subsequent column.) *p  0.01 vs. the other groups. Abbrevi-
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pproximately two-fold longer than in the other three
roups at 21 days after treatment.
igure 5. (A) Alkaline phosphatase stain showing a greater capillary
ensity in US/MB than the other groups on day 21. Bars indicate 50 m.
B) Such an effect was statistically significant on days 7 and 21. (n 12 for
aseline, three mice were used for each subsequent column.) *p 0.001 vs.
he other groups. Abbreviations as in Figure 2.
igure 6. (A) Photographs showing greater vascularity of treated skeletal
uscle in the US/MB group compared with the control group on day 21.
ars indicate 1 mm. (B) Vascularity quantified with the grid method was
reater in the US/MB group than in the other groups on days 7 and 21. (n
5 to 10 for each column.) *p 0.001 vs. the other groups. Abbreviations
s in Figure 2.
(
aISCUSSION
he major findings of the present study are: 1) microbubble
estruction by ultrasound can cause angiogenesis and can
ncrease vascularity and blood flow in the ischemic limbs; 2)
his phenomenon is associated with the recruitment of
nflammatory cells that produce VEGF; and 3) the neovas-
ularization thus produced parallels the improvement of
readmill time.
elivery of microbubbles to ischemic tissue. Angiogen-
sis by ultrasonic destruction of microbubbles was shown in
on-ischemic (12) or collateral-perfused skeletal muscles
11). We have shown in the present study that this method
an be applied to ischemic limbs in which resting blood flow
s limited, (15) and therefore the delivery of microbubbles
ith the same rheology as erythrocytes possibly would be
imited. The model used in the present study showed
pontaneous recovery of blood flow to approximately 50% of
hat of intact muscles seven days after the removal of the
rtery (15) when we performed US/MB treatment. In
ddition to the partial recovery of flow, the specific rheo-
ogic characteristics of this agent might play an important
ole in achieving a sufficient concentration of microbubbles
n the target region. A fraction of this agent shows transient
etention in the microcirculation after intravenous injection
igure 7. Augmented restoration of blood flow to the treated ischemic
imbs in the US/MB group. (n  12 for baseline, three mice were used for
ach subsequent column.) *p  0.05 vs. MB. †p  0.05 vs. the other
roups. Abbreviations as in Figure 2.
igure 8. Progressive prolongation of treadmill time in the US/MB group.
n 6 to 12 for each group.) *p 0.05 vs. the other groups. Abbreviations
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resumably because of the net negative surface charge
roviding complement-mediated attachment to the endo-
helium (18). A three-minute withholding time of ultra-
ound exposure before the first series of insonation allowed
ccumulation of microbubbles to a sufficient concentration
n the target ischemic planes in our experiment. In fact, we
bserved a dense opacification of the skeletal muscles on the
rst frames of the 20 frame bursts during the first series of
nsonation. Substantial opacification was also obtained dur-
ng the second series and thereafter with decreasing inten-
ities. Because we insonated five different planes with20-s
ntervals (99 cardiac cycles) in a series, the interval between
nsonation at a target transverse plane was: 20  5  100 s.
his long interval between bursts allowed a sufficient
oncentration of microbubbles in the plane because of their
ransient retention in the microcirculation (14). In addition,
ecause the opacification of the skeletal muscles rapidly
ecreased during a burst, it is speculated that microbubbles
ere sufficiently disrupted by the ultrasound energy and
onditions we used in the present study.
echanisms for angiogenesis and arteriogenesis. The
xact mechanism for these phenomena has not been eluci-
ated in previous studies, although inflammation after
njury was speculated to contribute. Therefore, we examined
he role of inflammatory cells in the angiogenesis especially
s the source of VEGF. We have directly shown that
nflammatory cell infiltration was augmented after the injury
reated by US/MB. The US/MB-recruited inflammatory
ells including macrophages and T-lymphocytes expressed
EGF, which was associated with the increase in capillary
ensity and vascularity and resting blood flow. Thus, the
ocal increase in concentration of VGFs secreted by infil-
rated inflammatory cells is likely to be the mechanism for
hese phenomena. However, further mechanism(s) for the
nduction of inflammatory cell infiltration by US/MB re-
ain(s) uncertain, although it was postulated that capillary
upture caused inflammation (14). The shock wave and
avitation produced by US/MB causes capillary rupture that
hanges shear stress to the endothelium and increases
xidative stress to the surrounding cells, which may initiate
he inflammatory process. Our previous studies have shown
hat this agent can be targeted to infiltrated macrophages
19,20). Therefore, it is possible that microbubbles were
elivered to the infiltrated leukocytes in the ischemic region
nd disrupted them at exposure to the ultrasound, and
hereby caused leakage of proinflammatory chemokines
rom these cells (19).
Although the number of capillaries was already greater in
he US/MB group 7 days after treatment, no further
ncrease in capillary density was noted at day 21. In contrast,
ascularity with a caliber size more than 0.01 mm increased
rom day 7 to day 21, which paralleled the improvement of
lood flow and treadmill time. Therefore, angiogenesis may
ot directly contribute to the improvement of limb function
ut preceded the increase in vascularity due to formation and increase in caliber of arterioles. Angiogenic factors
eleased from inflammatory mononuclear cells include basic
broblast growth factor (21) that activates several cell types
n the vascular wall (22) and dilates pre-existing vessels,
eferred to as arteriogenesis, rather than the new growth of
apillaries to which VEGF contributes (23). Although we
id not show the augmentation of local expression of
rowth factors other than VEGF, it is likely that expression
f other factors was also enhanced either directly or indi-
ectly by US/MB, which resulted in a delayed increase in
lood vessels larger than capillaries.
linical implications. An increase in vascularity produced
y US/MB could be a mere unorganized and useless post-
nflammatory process, whereas both capillary rupture and
ubsequent inflammation could be harmful to the tissue,
anceling the benefit of neovascularization. Therefore, we
valuated the function of treated limbs as determined by
xercise capacity by using the treadmill test used in previous
linical studies on therapeutic angiogenesis for arterial
cclusive disease in lower limbs (1). Recovery of treadmill
ime was significantly augmented by the US/MB treatment,
hich resulted in a two-fold increase on day 21. Thus, the
ost-inflammatory angiogenesis produced by US/MB is
aluable, although possible neuroablation by US/MB could
lso contribute to the improved treadmill time by reducing
ain perception. Therefore, although creation of injury to
he ischemic skeletal muscles is requisite, the net outcome of
his method is profitable. In addition, this method can
liminate the potential risk of local infection in the ischemic
egion caused by trans-cutaneous injection. Moreover, the
oninvasiveness of this method also allows repeated treat-
ent to potentially maximize the effects.
tudy limitations. There are several limitations to this
tudy. We tested the method only in small animals, which
rovided an ideal condition for insonation. For the appli-
ation to patients, the insonation condition needs to be
ptimized to obtain the best improvement of leg function,
hich may include the tradeoff between the deterioration
irectly caused by the acoustic injury and the improvement
y angiogenesis after the injury. Future studies to optimize
he bioeffects should include ultrasound dosimetry, optimi-
ation of frequency, pulse cycle length, and acoustic inten-
ity, as well as identification or fabrication of effective
icrobubbles and their doses.
Second, although the net outcome of this method was
eneficial, none of the possible adverse effects, including
ain, fever, and systemic inflammatory response, were ad-
ressed.
Third, the model we used is for acute limb ischemia that
hows spontaneous angiogenesis without treatments (15).
herefore, it remains to be clarified whether this method
ay be applicable to chronic stable ischemia or to only
lightly ischemic or normal tissues showing little spontane-
us angiogenesis. Possible options for enhancing the efficacy
n such settings may include systemic co-administration of
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24) and granulocyte-colony-stimulating factor (25). Possi-
le advantageous effects of the repeated application of this
inimally invasive method may also be worth testing in
uture studies. This may be especially beneficial in the case
f severe ischemia that limits microbubble supply to the
entral zone of ischemic regions. Microbubbles delivered to
he marginal zone of the ischemic area can produce neovas-
ularization that provides flow for the microbubble delivery
n the subsequent session.
Finally, effects of other agents clinically used in treating
bstructive arterial disease, including angiotensin II type-1
eceptor antagonists that exert anti-inflammatory actions
15), remain to be examined in the future.
ONCLUSIONS
ecruitment of inflammatory cells in ischemic skeletal
uscle in mice by ultrasonic microbubble destruction can
nduce angiogenesis resulting in increased vascularity and
lood flow, which leads to functional improvement. Our
ata may provide a basis for developing a safe and useful tool
or therapeutic angiogenesis.
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